Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 335-342

  Maguire, Janet J ^a   Kuc, Rhoda E ^a   Rous, Brian A ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antagonist potency; BQ123; Endothelin receptor subtypes; Human saphenous vein; In vitro pharmacology; Saturation and competition binding; 125I ET 1; 125I S6b

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; IODINE 125; SARAFOTOXIN;

ADULT; AGED; AORTA; ARTICLE; BINDING SITE; CONTROLLED STUDY; DESENSITIZATION; DISSOCIATION; DRUG BINDING; DRUG POTENCY; FEMALE; HOMOGENATE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY; SAPHENOUS VEIN; TIME; VASOCONSTRICTION;

EID: 0029923248     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15407.x     Document Type: Article

References (44)

1. AMBAR, I., KLOOG, Y., SCHVARTZ, I., HAZUM, E. & SOKOLOVSKY, M. (1989). Competitive interaction between endothelin and sarafotoxin: binding and phosphoinositides hydrolysis in rat atria and brain. Biochem. Biophys. Res. Commun., 158, 195-201.
2. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. & NAKANASHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
4. BACON, C.R. & DAVENPORT, A.P. (1996). Endothlin receptors in human coronary artery and aorta. Br. J. Pharmacol., 117, 986-992.
5. BAX, WA., AGHAI, Z., VAN TRICHT, C.L.J., WASSENAAR, C. & SAXENA, P.R. (1994). Different endothelin receptors involved in the endothelin-1- and sarafotoxin S6b-induced contrations of the human isolated coronary artery. Br. J. Pharmacol., 113, 1471-1479.
6. BAX, W.A., BOS, E. & SAXENA, P.R. (1993a). Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur. J. Pharmacol., 239, 267-268.
7. BAX, W.A., BRUINVELS, A.T., VAN SUYLEN, R.-J., SAXENA, P.R. & HOYER, D. (1993b). Endothelin receptors in the human coronary artery, ventricle and atrium: A quantitative autoradiographic analysis. Naunyn-Schmied. Arch. Pharmacol., 348, 403-410.
8. BAX, W.A. & SAXENA, P.R. (1994). The current endothelin receptor classification: time for a reconsideration? Trends Pharmacol. Sci., 15, 379-386.
9. 125I-endothelin-1 binding sites in human umbilical artery. Eur. J. Pharmacol., 249, 299-305.
10. BOUSSO-MITTLER, D., KLOOG, Y., WOLLBERG, Z., BDOLAH, A., KOCHVA, E. & SOKOLOVSKY, M. (1989). Functional endothelin/ sarafotoxin receptors in the rat uterus. Biochem. Biophys. Res. Commun., 162, 952-957.
11. DAVENPORT, A.P. & MAGUIRE, J.J. (1994). Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol. Sci., 15, 9-11.
12. DAVENPORT, A.P., MORTON, A.J. & BROWN, M.J. (1991). Localization of Endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney. J. Cardiovasc: Pharmacol., 17 (Suppl. 7), S152-S155.
13. A subtype. Br. J. Pharmacol., 114, 1110-1116.
14. B receptors in human vascular smooth muscle. J. Cardiovasc. Pharmacol., 22 (Suppl. 8), S22-S25.
15. EGLEZOS, A. CUCCHI, P., PATACCHINI, R. QUARTARA, L., MAGGI, C.A. & MIZRAHI, J. (1993). Differential effects of BQ123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor. Br. J. Pharmacol., 109, 736-738.
16. GALRON, R., BDOLAH, A., KLOOG, Y. & SOKOLOVSKY, M. (1990). Endothelin/sarafotoxin receptor induced phosphoinositide turnover: effects of pertussis and cholera toxins and of phorbal ester. Biochem. Biophys. Res. Commun., 171, 949-954.
17. GODFRAIND, T. (1993). Evidence for receptor heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol., 110, 1201-1205.
18. 125I]-endothelin. Eur. J. Pharmacol., 162, 509-510.
19. GULATI, A. & REBELLO, S. (1992). Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology, 31, 243-250.
20. HAY, D.W.P., LUTTMANN, M.A., HUBBARD, W.C. & UNDEM, B.J. (1993). Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br. J. Pharmacol., 110, 1175-1183.
21. HIRATA, Y., YOSHIMI, H., YAKAICHI, S., YANAGISAWA, M. & MASAKI, T. (1988). Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett., 239, 13-17.
22. A receptor. Life Sci., 50, 247-255.
23. 125I]sarafotoxin S6b binding in rat tissues. Eur. J. Pharmacol., 183, 1746.
24. B in human kidney. Kidney Int., 44, 36-42.
25. KLOOG, Y., AMBAR, L. SOKOLOVSKY, M., KOCHVA, E., BDOLAH, A. & WOLLBERG, Z. (1988). Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science, 242, 268-270.
26. KLOOG, Y., BOUSSO-MITTLER, D., BDOLAH, A. & SOKOLOVSKY, M. (1989). Three apparent receptor subtypes for the endothelin/ sarafotoxin family. FEBS Lett., 253, 199-202.
27. MCPHERSON, G. (1983). A pratical computer-based approach to the analysis of radioligand binding experiments. Comput. Prog. Biomed., 17, 107-114.
28. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol., 115, 191-197.
29. MAGUIRE, J.J., KUC, R.E., O'REILLY, G. & DAVENPORT, A.P. (1994). Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br. J. Pharmacol., 113, 49-54.
30. 125I]S6b binding with subnanomolar affinity but is a more potent antagonist of S6b vasoconstriction in human isolated blood vessels. Br. J. Pharmacol., 114, 75P.
31. MARTIN, E.R., MARSDEN, P.A., BRENNER, B.M. & BALLERMANN, B.J. (1989). Identification and charaterization of endothelin binding sites in rat renal papillary and glomerular membranes. Biochem. Biophys. Res. Commun., 162, 130-137.
32. MORELAND, S., MCMULLEN, D.M., DELANEY, C.L., LEE, V.G. & HUNT, J.T. (1992). Venous smooth muscle contains vasoconstrictor ET(B)-like receptors. Biochem. Biophys. Res. Commun., 184, 100-106.
33. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem., 107, 220-239.
34. RIEZEBOS, J., WATTS, I.S. & VALLANCE, P.J.T. (1994). Endothelin receptors mediating functional responses in human small arteries and veins. Br. J. Pharmacol., 111, 609-615.
35. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. & MASAKI, T. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature, 348, 732-735.
36. SALOM, J.B., TORREGROSA, G., BARBERÁ, M.D., JOVER, T. & ALBORCH, E. (1993). Endothelin receptors mediating contraction in goat cerebral arteries. Br. J. Pharmacol., 109, 826-830.
37. SOKOLOVSKY, M. (1992). Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signalling. Pharmacol. Ther., 54, 129-149.
38. SOKOLOVSKY, M. (1994). Endothelins and sarafotoxins: receptor heterogeneity. Int. J. Biochem., 26, 335-340.
39. B receptors mediating venous smooth muscle contraction. Biochem. Biophys. Res. Commun., 200, 627-633.
40. B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol., 107, 858-860.
41. WARNER, T.D., ALLCOCK, G.H., CORDER, R. & VANE, J.R. (1993). Use of the endothelin antagonists BQ123 and PD142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br. J. Pharmacol., 110, 777-782.
42. B contractile receptors. Eur. J. Pharmacol., 257, 307-310.
43. WILLIAMS, D.I., JR., JONES, K.L., PETTIBONE, D.J., LIS, E.V. & CLINESCHMIDT, B.V. (1991). Sarafotoxin 6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun., 175, 556-561.
44. B receptors mediating tracheal smooth muscle contraction. Biochem. Biophys. Res. Commun., 207, 668-674.